Republic of Korea

5 Vaccines Approved for Use in Republic of Korea

Protein Subunit

Novavax

Nuvaxovid

Approved in 37 countries
15 trials in 12 countries
Approval Source: reuters.com
RNA

Moderna

Spikevax

Approved in 86 countries
63 trials in 22 countries
Approval Source: modernatx.gcs-web.com
RNA

Pfizer/BioNTech

Comirnaty

Approved in 146 countries
80 trials in 26 countries
Approval Source: asia.nikkei.com
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries
Approval Source: mfds.go.kr
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 140 countries
63 trials in 30 countries
Approval Source: reuters.com

9 in Clinical Trials in Republic of Korea

Protein Subunit

SK Bioscience Co Ltd

GBP510

6 trials in 6 countries
DNA

Inovio

INO-4800

9 trials in 9 countries
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 140 countries
63 trials in 30 countries
Protein Subunit

EuBiologics Co Ltd

EuCorVac-19

2 trials in 1 country
DNA

GeneOne Life Science, Inc.

GLS-5310

4 trials in 2 countries
Replicating Viral Vector

Cellid Co

AdCLD-CoV19

2 trials in 1 country
Protein Subunit

SK Bioscience Co Ltd

NBP2001

Protein Subunit

HK inno.N Corporation

IN-B009

Non Replicating Viral Vector

Cellid Co

AdCLD-CoV19-1

1 Vaccines with Trials in Republic of Korea are No Longer Progressing

DNA

Genexine

GX-19

7 trials in 1 country